Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis
Cardiovascular Drugs and Therapy · 2025-12 · 39 (6) · 1289-1301
DOI: 10.1007/s10557-024-07659-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 24.12.2024. Verfasst von Bozhi Ye und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Panvascular Disease Management Center (PDMC), Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical Univ…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Emodin, Atherosclerosis, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Taizhou Municipal Science and Technology Bureau, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: Inflammatory responses induced by NLRP3 inflammasome contribute to the progression of atherosclerosis. This study seeks to investigate the effect of emodin on the NLRP3 inflammasome in atherogenesis and to probe the underlying mechanism. METHODS: ApoE-knockout (ApoE-/-) mice were treated with a high-fat diet (HFD) for 12 weeks and intragastrically with emodin for 6 weeks. Human mononuclear cell line THP-1 was pretreated with emodin or signaling pathway inhibitors and induced into macrophages using phorbol 12-myristate 13-acetate (PMA) for 48 h. The NLRP3-mediated inflammatory response was studied both in vivo and in vitro. The level of the inflammation was detected by western blot, real-time PCR analysis, and ELISA. RESULTS: Emodin attenuated atherosclerotic lesions in HFD-treated ApoE-/- mice. Emodin dramatically decreased the expression of NLRP3, GSDMD, IL-1β, and IL-18 in HFD-treated ApoE-/- mice and PMA-induced macrophages. Moreover, emodin significantly hindered the activation of nuclear factor kappa-B (NF-κB) by inhibiting the formation of the TLR4/MyD88 complex in PMA-induced macrophages. CONCLUSION: Our data demonstrate that emodin can inhibit the development of atherosclerotic plaques by alleviating NLRP3/GSDMD-induced inflammation through repressing the TLR4/MyD88/NF-κB signaling pathway in macrophages. This finding suggests that emodin can be a potential candidate for the treatment of atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Panvascular Disease Management Center (PDMC), Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, WenZhou, ZheJiang, China.
- The Key Laboratory of Cardiovascular Disease of Wenzhou, Department of Cardiology, The First Affiliated Hospital of WenZhou Medical University, WenZhou, ZheJiang, China.
- Department of Emergency, The First Affiliated Hospital of Wenzhou Medical University, WenZhou, Zhejiang, China.
- Department of Cardiology, Yuhuan County People's Hospital of Zhejiang Province, Taizhou, China. laixianhui21@163.com.
- The Key Laboratory of Cardiovascular Disease of Wenzhou, Department of Cardiology, The First Affiliated Hospital of WenZhou Medical University, WenZhou, ZheJiang, China. susiehzq@126.com.
- Department of Cardiology, Panvascular Disease Management Center (PDMC), Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, WenZhou, ZheJiang, China. 13758453137@163.com.
ORCID-Profile: Zhuyin Jia
Förderung
- Taizhou Municipal Science and Technology Bureau
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- Zhejiang Traditional Chinese Medicine Administration
- Science and Technology Plan Project of Wenzhou Municipality
- Major Scientific and Technological Innovation Project of Wenzhou
Zitieren
APA
Ye, B., Cai, X., Liang, X., Chen, Y., Dai, S., Huang, Z., Huang, W., Zhang, L., Wang, Z., Xing, J., Lai, X., Huang, Z., & Jia, Z. (2025). Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis. Cardiovascular Drugs and Therapy, 39(6), 1289-1301. https://doi.org/10.1007/s10557-024-07659-w
Vancouver
Ye B, Cai X, Liang X, Chen Y, Dai S, Huang Z, et al. Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis. Cardiovascular Drugs and Therapy. 2025;39(6):1289-1301. doi:10.1007/s10557-024-07659-w
BibTeX
@article{Ye2025,
author = {Ye, Bozhi and Cai, Xueli and Liang, Xiaohe and Chen, Yunxuan and Dai, Shanshan and Huang, Zhuqi and Huang, Weijian and Zhang, Lei and Wang, Zixuan and Xing, Jincheng and Lai, Xianhui and Huang, Zhouqing and Jia, Zhuyin},
title = {Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
volume = {39},
number = {6},
pages = {1289--1301},
doi = {10.1007/s10557-024-07659-w}
}
EUVIMED